LUPIN vs UNICHEMLAB: Stock Comparison

Lupin Limited vs Unichem Laboratories Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Lupin Limited is the larger company by market capitalisation. Lupin Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Unichem Laboratories Ltd shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Lupin Limited and Unichem Laboratories Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LUPIN is more favourable on 10 of 13 scored metrics and UNICHEMLAB on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
LUPIN is the larger company
₹1.08 L Cr vs ₹3,790 Cr
P/E Ratio
UNICHEMLAB has a lower P/E
15.03x vs 20.35x
P/B Ratio
UNICHEMLAB has a lower P/B
1.4x vs 4.83x
EPS
LUPIN has higher earnings per share
₹116.56 vs ₹35.9
Dividend Yield
LUPIN has a higher dividend yield
0.48% vs 0%
Revenue Growth (TTM YoY)
LUPIN has faster revenue growth
31.9% vs -2.1%
EPS Growth (TTM YoY)
LUPIN has faster EPS growth
89% vs -79.3%
Qtr Sales Growth
LUPIN has stronger quarterly sales growth
31.9% vs -2.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLUPINUNICHEMLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLUPINUNICHEMLAB
Live Price₹2,370.5₹537.35
Day Change-1.08%1.19%
Volume7.26 L63,182
52-Week High₹2,529.5₹687.2
52-Week Low₹1,836.8₹278.2
Distance from 52W High-6.29%-21.81%

Valuation

MetricLUPINUNICHEMLAB
Market Cap₹1.08 L Cr₹3,790 Cr
P/E Ratio20.35x15.03x
P/B Ratio4.83x1.4x
EPS₹116.56₹35.9
Book Value₹491.29₹386
Dividend Yield0.48%0%

Growth

MetricLUPINUNICHEMLAB
Revenue Growth (TTM YoY)31.9%-2.1%
EPS Growth (TTM YoY)89%-79.3%
Qtr Sales Growth31.9%-2.05%
Qtr Profit Growth101%-65.8%

Profitability & Leverage

MetricLUPINUNICHEMLAB
ROE29.1%3.17%
ROCE30.3%4.13%
Net Margin17.65%11.48%
Operating Margin31.5%8.57%
Debt to Equity0.29x0.18x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricLUPINUNICHEMLAB
Promoter Holding46.57%70.22%
FII Holding22.42% 0.71 pp0.9% 0.1 pp
DII Holding24.65% 0.67 pp10.46% 0.17 pp
Public Holding6.08% 0.03 pp18.42% 0.27 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Lupin Limited and Unichem Laboratories Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.